Month: February 2023

FDA Approves Jesduvroq (daprodustat) for Anemia Caused by Chronic Kidney Disease for Adults on Dialysis February 01, 2023 — Today, the U.S. Food and Drug Administration approved Jesduvroq tablets (daprodustat) as the first oral treatment for anemia (decreased number of red blood cells) caused by chronic kidney disease for adults who have been receiving dialysis
0 Comments
February 01, 2023 — IBSA Pharma Inc. is voluntarily recalling 27 lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution to the consumer level. This voluntary recall has been initiated because these lots may be subpotent. The company’s analyses show a slight decrease below 95.0% of its labeled amount in levothyroxine sodium (T4) for some lots. This
0 Comments
According to research, more than a quarter of medical students report feeling depressed. What is perhaps even more concerning is that less than one in five of those students seek psychiatric treatment. Why are so many medical students depressed and why do so few seek help? To start, medical school is highly competitive. Everyone is
0 Comments
Roughly 4 decades after she first started menstruating, Elizabeth Flanagan finally underwent surgery to repair damage wreaked on her body by endometriosis. She’d spent years struggling with a variety of seemingly random symptoms, from migraines to excruciatingly painful periods to fatigue and irritable bowel syndrome. She’d worried about abnormal labs, including “extremely high” ANA, creatinine,
0 Comments
Migraine usually affects women more than men. A new study has found that the condition can also increase the risk of complications during pregnancy. The study, published in the journal Neurology, was led by investigators from Brigham and Women’s Hospital, Boston. It was reported that migraine diagnosed pre-pregnancy was associated with adverse outcomes during pregnancy,
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. It’s the end of an era. The Biden administration announced Monday that it will be ending the twin COVID-19 emergency declarations, marking a major change in the 3-year-old pandemic. The orders spanned two presidencies. The Trump administration’s Health and Human Services
0 Comments
New research has found some antidepressants may be effective in treating certain chronic pain conditions, but others lack convincing evidence on their effectiveness. Many people are unaware that some antidepressants (medications used to treat people living with depression) are also being prescribed to treat certain chronic pain conditions. Chronic pain affects between one-third and one-half
0 Comments
Recent advances in newborn heart surgery have greatly reduced brain injuries in infants with congenital heart disease, according to a 20-year study by scientists at UCSF Benioff Children’s Hospitals and British Columbia Children’s Hospital (BCCH). The study, begun in 2001 and published this month in the Journal of the American College of Cardiology, analyzed brain
0 Comments
While some antidepressant drugs were effective for certain pain conditions, most were either ineffective or evidence was inconclusive, a review found. Evidence of efficacy of antidepressants for pain emerged in 11 of 42 comparisons included in an overview of systematic reviews, reported Giovanni Ferreira, PhD, of the University of Sydney, and colleagues. In four of
0 Comments
Parents have been warned of the negative effects of too much screen time for their babies. A new study found that infants exposed to computer, TV and phone screens for hours could suffer lower cognitive skills later in life.  In a study titled “Associations Between Infant Screen Use, Electroencephalography, Markers and Cognitive Outcomes,” published Monday
0 Comments
Here are 3 tips to help you achieve superhuman productivity. Number one, be respectful of your time. Time is our most valuable asset, yet most of us don’t treat it as such. Although I can’t tell you exactly how you should spend your time, make sure it aligns with your priorities and life goals. Number
0 Comments
Running does not appear to cause sustained wear and tear of healthy knee cartilage, with research suggesting that the small, short-term changes to cartilage after a run reverse within hours. A systematic review and meta-analysis published in the most recent issue of Osteoarthritis and Cartilage presents the findings involving 396 adults, which compared the “before”
0 Comments
Whatever route we explore to achieve it, and whatever unique barriers we face, there is a unifying desire that connects us all: to nurture our wellbeing In my time doing this job, I’ve sat down with a lot of different people. I’ve chatted with global superstars, actors, singers, and models. But also, artists, activists, authors,
0 Comments
Researchers have found that a focused ultrasound technique, known as sonobiopsy, can release more neurodegenerative disorder biomarkers in the blood to ease the diagnosis of the diseases. The study, published Tuesday in the journal Radiology, found a non-invasive method to detect biomarkers in blood that were previously restricted by the blood-brain barrier. Focused-ultrasound-mediated liquid biopsy
0 Comments
Can a Virtual Assistant Help People With Diabetes and Depression? – Diabetes Daily Learning Center Learning Center: LearningCenter Diabetes Daily does not provide medical advice,diagnosis or treatment.Get additional information.© 2005 – 2023 Everyday Health, Inc., a Ziff Davis company. Everyday Health is among the federally registered trademarks of Everyday Health, Inc. and may not be
0 Comments
Functions like sensing and pacing in implantable cardioverter defibrillators (ICD) tend to resist interference from the energy fields generated by MRI, as long as device programming is properly adjusted before the scan. That applies even to patients with older “legacy” devices implanted before the 2015 advent of MRI-conditional ICDs despite, in practice, prevalent but misguided
0 Comments
SAN DIEGO and TORONTO, Jan. 30, 2023. Aptose Biosciences Inc. (“Aptose”) today announced the 120 mg monotherapy dosing of patients in the APTIVATE Phase 1/2 clinical trial of tuspetinib (formerly HM43239), an oral, mutation agnostic tyrosine kinase inhibitor (TKI) being developed for the treatment of patients with relapsed or refractory acute myeloid leukemia (R/R AML).
0 Comments
Vials and a medical syringe seen displayed in front of the Food and Drug Administration (FDA) of the United States logo. FDA finds the COVID-19 vaccine. Pavlo Gonchar | LightRocket | Getty Images The Food and Drug Administration on Tuesday said its emergency authorizations of Covid vaccines, tests and treatments will not be impacted by
0 Comments